International Flavors & Fragrances (NYSE:IFF) reported a stronger-than-expected start to 2026, with first-quarter sales growth across all business segments, higher adjusted profitability and improved ...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...
Food is increasingly taking center stage as a primary reason for travel, with more Asian travelers eager to explore destinations that offer unforgettable culinary experiences. Reflecting this shift, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
APsystems (SH.688348), a leading provider of distributed PV and energy storage solutions, has released its 2025 ESG Sustainability Report – the company's third consecutive annual disclosure. The ...
If you are wondering whether Element Solutions stock still offers value after its recent run, it helps to start by looking at what the market has already priced in. The share price recently closed at ...
Enliven Therapeutics, Inc. (NASDAQ:ELVN) is one of the best performing healthcare stocks so far in 2026. On April 30, Mizuho ...
In recent weeks, Intuitive Machines has outlined ambitious 2026 revenue guidance of US$900 million to US$1 billion following ...
If you are wondering whether Boeing's current share price still offers value, the key is understanding what the recent moves ...
The U.S. FDA recently highlighted Amgen’s role in its real‑time clinical trials initiative, confirming the initiation of ...
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Strong Recent Share Price Run
Recent performance and context for Indivior Pharmaceuticals Indivior Pharmaceuticals (INDV) has drawn fresh attention after a strong recent run, with the stock up about 30% over the past month and 15% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results